JAK2 variations and functions in lung adenocarcinoma
Lung cancer ranks as the first most common cancer and the first leading cause of cancer-related death in China and worldwide. Due to the difficulty in early diagnosis and the onset of cancer metastasis, the 5-year survival rate of lung cancer remains low. JAK2 has emerged as pivotal participant in b...
Saved in:
| Main Authors: | Yanjun Xu, Juan Jin, Jiawei Xu, Yang W Shao, Yun Fan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-06-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317711140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
by: Hongmei Zheng, et al.
Published: (2025-03-01) -
ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2/STAT3 signaling pathway
by: Mingming Xu, et al.
Published: (2025-07-01) -
HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1/JAK1/FGL1 axis in lung adenocarcinoma
by: Tao Yu, et al.
Published: (2024-10-01) -
Decoding epithelial–fibroblast interactions in lung adenocarcinoma through single-cell and spatial transcriptomics
by: Jiajin Yang, et al.
Published: (2025-07-01) -
Sirtuin family in lung adenocarcinoma
by: Cui Chen, et al.
Published: (2025-07-01)